Table 3.
LDM | NLDM | P value | |
---|---|---|---|
No. of patients | 37 | 55 | – |
Previousembryo transfer | 1.60 ± 0.58 | 1.48 ± 0.62 | 0.3129a |
Multigravida patients | 17 (%) | 32 (%) | 0.2108b |
Multipara patients | 7 (%) | 20 (%) | 0.0631 *b |
Patients with miscarriage | 15 (%) | 17 (%) | 0.3740b |
Patients with chronic endometriosis | 3 (%) | 11 (%) | 0.3933)b |
Patients with endometriosis | 3 (%) | 4 (%) | 0.8826)b |
Patients with endometrial polyp | 3 (%) | 3 (%) | 0.6165)b |
Serum AMH, ng/mL | 3.25±2.91 | 3.60±2.69 | 0.4240a |
Serum TSH >2.50 μIU/mL | 6 (%) | 7 (%) | 0.5791)b |
% of endometrial Lactobacillus* | 99.4 (92.3–100) | 5.4 (0.0–89.7) | - |
*Values presented as median (range); aStudent’s t-test. bChi-square test.
AMH, anti mullerian hormone LDM, Lactobacillus-dominated microbiota; NLDM, non-Lactobacillus-dominated microbiota; TSH, thyroid stimulating hormone.